Planning pregnancy with type 1 diabetes starts before a positive pregnancy test. A preconception review helps the diabetes and pregnancy teams assess glucose patterns, kidney health, thyroid function, medicines, and existing complications while there is time to address concerns.
Common laboratory discussions include hemoglobin A1C, serum creatinine, urine albumin-to-creatinine ratio (uACR), and thyroid-stimulating hormone (TSH). Other tests depend on medical history and routine preconception needs. Ulta Lab Tests offers relevant laboratory options for eligible patients, but selection and interpretation should be coordinated with the clinicians who will manage pregnancy.
This article focuses on established type 1 diabetes before conception. The Pregnancy Blood Tests and Prenatal Screening guide covers the broader pregnancy-testing pathway. The Diabetes and Prediabetes Blood Tests pillar provides general laboratory context.
Early fetal development begins before many people recognize pregnancy. Preconception care creates an opportunity to improve glucose management and review conditions that can affect pregnancy. It also allows discussion of contraception until the person and care team agree that the management plan is ready. This is a shared planning process, not a pass-or-fail judgment based on one result. [1]
The team may include an endocrinologist or another clinician experienced in type 1 diabetes, an obstetric clinician with diabetes expertise, a diabetes educator, and a registered dietitian. Kidney or other specialist input may be appropriate when complications are present.
If pregnancy has already occurred, contact the diabetes and prenatal teams promptly. Do not wait until every laboratory result is available, and do not abruptly stop insulin or other prescribed treatment while seeking advice.
Bring recent laboratory reports, glucose records, a medication and supplement list, and the dates of eye and other complication assessments. Explain previous severe hypoglycemia, ketoacidosis, pregnancy complications, kidney findings, thyroid disease, and any barriers to obtaining insulin or supplies.
| Situation or concern | Laboratory discussion | Care beyond laboratory testing |
|---|---|---|
| Pregnancy planned in the coming months | A1C and review of due kidney and thyroid tests | Glucose goals, contraception, medicines, nutrition, and specialist coordination |
| Frequent low readings or wide glucose swings | A1C interpreted with glucose records | Hypoglycemia prevention, device settings, and individualized treatment review |
| Previous urinary albumin, reduced kidney function, or hypertension | Serum creatinine and uACR | Blood pressure, trends, medication safety, and possible nephrology review |
| Type 1 diabetes with known or possible thyroid disease | TSH and selected free T4 | Symptoms, current treatment, and a plan for early pregnancy reassessment |
| Fatigue, bleeding history, or known anemia | CBC and cause-directed additions when appropriate | Nutrition, blood loss, and interpretation of A1C |
| Uncertain immunity or missing routine screening records | Tests selected by the preconception clinician | Vaccination timing and standard reproductive-health care |
Known type 1 diabetes is preexisting diabetes, not gestational diabetes. The glucose-load screening pathway used to look for gestational diabetes in someone without established diabetes is not the routine pathway for confirming an already established type 1 diagnosis.
| Test | What it contributes | Result meaning and limitation |
|---|---|---|
| Hemoglobin A1C | Recent average glucose exposure; helps assess preconception management | A higher value may identify an opportunity to improve glycemia. A lower value does not prove freedom from hypoglycemia or post-meal highs. |
| Serum creatinine | A blood marker used to assess kidney filtration and establish a baseline | A higher value can suggest impaired filtration, but muscle mass and other factors matter. Pregnancy changes expected values and interpretation. |
| Urine albumin-to-creatinine ratio (uACR) | Urinary albumin relative to concentration; helps identify kidney damage | Persistent elevation warrants evaluation. A transient elevation does not by itself establish chronic kidney disease. |
| Thyroid-stimulating hormone (TSH) | A starting thyroid-function measurement, relevant because thyroid autoimmunity can coexist with type 1 diabetes | High or low values need clinical interpretation. Pregnancy changes the appropriate interpretive framework. |
| Free T4, when indicated | Clarifies thyroid hormone status when results, symptoms, or treatment require it | Interpret with TSH and the laboratory method. Pregnancy-related binding changes complicate some thyroid assays. |
| Complete blood count (CBC), when due or indicated | Assesses anemia and other blood-cell findings | Low hemoglobin prompts cause investigation; a CBC does not measure all nutrients or establish why anemia developed. |
| Lipid panel, when due or relevant to medication review | Supports a preconception cardiovascular and treatment review | Abnormal results need context. Pregnancy alters lipid physiology, so interpretation after conception differs. |
The linked urine product is Albumin, Random Urine with Creatinine. Its creatinine measurement adjusts for urine concentration; it does not replace the separate serum creatinine assessment. A larger chemistry panel may already contain the blood measurement, so review an existing order before adding duplicates.
ADA guidance generally aims for an A1C below 6.5% before conception when achievable without excessive hypoglycemia. The target should be individualized, particularly when there is a history of severe lows or other complicating factors. A clinician can help balance benefit with safety. [1,2]
A1C cannot display overnight lows, post-meal rises, or day-to-day variability. Review meter or sensor data alongside the laboratory result. An average that looks favorable may combine high and low readings that require attention.
Red-cell turnover, anemia, recent blood loss or transfusion, and some hemoglobin conditions can change the relationship between A1C and actual glycemia. Pregnancy itself changes this relationship. If the number and glucose records disagree, investigate why rather than making a treatment change from either in isolation. [3]
Serum creatinine contributes to the filtration assessment. uACR looks for albumin leaking into urine. Kidney disease can be present even when one of these measurements is reassuring, so they are complementary rather than interchangeable.
A baseline also helps the care team interpret later changes. The result belongs alongside blood pressure, prior kidney trends, diabetes duration, and medication history. Known kidney disease may change pregnancy counseling, monitoring, and the specialists involved. [4]
Standard eGFR equations are not valid during pregnancy. Renal assessment relies on serum creatinine and appropriate specialist interpretation instead of applying a nonpregnant eGFR threshold. Urinary protein assessment during pregnancy is also selected within the prenatal care plan. [5]
A preconception uACR does not predict every pregnancy complication, and it cannot diagnose preeclampsia before pregnancy. Later symptoms or blood-pressure changes require obstetric assessment. The Kidney Function Tests guide explains the general distinction between filtration and urinary albumin.
Autoimmune thyroid conditions are more common in people with type 1 diabetes. A thyroid review before conception gives the clinician time to assess existing disease, interpret an abnormal TSH, and plan follow-up. Symptoms such as fatigue or weight change alone are too nonspecific to establish a thyroid diagnosis. [6]
Free T4 and further evaluation may be useful when the initial result, symptoms, or treatment history warrants them. Thyroid antibodies are not a universal addition to every preconception order. If pregnancy occurs, notify the clinician managing thyroid treatment promptly because testing and treatment requirements may change.
Read the Thyroid Blood Tests pillar for the broader testing framework. Use pregnancy-specific interpretation once pregnant rather than applying one general internet reference range.
These stages do not replace a full appointment. Eye assessment, medication review, nutrition and folate counseling, vaccination review, and a plan for sick days and severe hypoglycemia remain important even when laboratory findings are within range.
Imagine an A1C near the agreed goal but sensor records showing repeated overnight lows. The next discussion concerns glucose safety, not simply obtaining a still-lower laboratory value. Alternatively, an elevated uACR with a reassuring serum creatinine calls for review of urinary findings and persistence rather than dismissal based on filtration alone.
A third person may have reassuring diabetes results but a newly abnormal TSH. That creates a separate thyroid question. These examples illustrate why the care plan should reflect the combination of findings and the person's history.
No combination of normal results guarantees a complication-free pregnancy. The value of preconception testing is to identify actionable concerns and create a documented baseline for ongoing care.
Arrange testing with enough time for clinical follow-up before trying to conceive when possible. A1C alone does not require fasting; other components may have specific instructions. Confirm how to manage food and insulin safely if a fast is requested. Never omit essential insulin solely to prepare for blood work.
Follow urine-collection instructions and report infection, menstruation, recent vigorous exercise, or marked hyperglycemia. Tell the clinician about supplements, including biotin, and recent illness or blood loss.
Bring every prescription and over-the-counter product to the medication review. Some medicines used for blood pressure, cholesterol, or other conditions may need changes before pregnancy. The prescribing clinician should make an individualized plan; do not abruptly discontinue treatment from an article or laboratory flag.
Eligible patients can review relevant tests and current ordering requirements through Ulta Lab Tests. Coordinate with the pregnancy and diabetes teams before purchasing, avoid duplicate orders, and confirm who will review results. Online access can help organize a planned evaluation, but it cannot provide pregnancy clearance.
See Direct-Access Lab Testing for the service workflow. If already pregnant and experiencing persistent vomiting, abnormal breathing, confusion, or inability to keep fluids down, seek urgent medical care. Do not wait for routine outpatient testing.
Arrange a preconception visit before trying to conceive, allowing time to review glucose management, complications, medicines, and relevant tests. The amount of preparation needed differs between individuals. If pregnancy occurs before that review, contact the diabetes and prenatal teams promptly rather than waiting to complete a self-selected laboratory panel first.
ADA guidance generally recommends below 6.5% when achievable without excessive hypoglycemia. This is a planning goal, not an instruction to adjust insulin independently or a guarantee of a particular pregnancy outcome. The clinician should individualize it using glucose records, previous severe lows, existing complications, and the person's circumstances.
It provides useful information but cannot answer the whole question. Daily glucose patterns, kidney and thyroid health, eye findings, medication safety, nutrition, and access to care also matter. A1C may miss significant highs and lows. Readiness is discussed with the care team rather than established by a single laboratory result.
Serum creatinine and uACR assess different aspects of kidney health. Filtration can appear reassuring while urinary albumin is elevated. Reviewing both, when indicated, gives a more useful baseline. A urine abnormality needs interpretation with collection conditions, blood pressure, previous results, and appropriate confirmation rather than an immediate assumption about its cause.
Standard estimating equations are not valid for assessing renal function during pregnancy. The care team interprets serum creatinine and other appropriate findings in the pregnancy context. A printed eGFR should therefore not be used independently to reassure or alarm someone who is pregnant. Discuss renal results with the prenatal or kidney specialist.
Established type 1 diabetes is preexisting diabetes and requires its own pregnancy-management pathway. A glucose-load screening test intended to detect gestational diabetes does not replace that care. The prenatal team will arrange other routine pregnancy screening and determine how glucose, complications, and fetal well-being should be monitored throughout pregnancy.
A preconception thyroid review is useful in type 1 diabetes because autoimmune thyroid disease can coexist and treatment needs may affect planning. TSH is a common starting measurement, with free T4 when indicated. If already receiving thyroid treatment, arrange an explicit plan for contacting the clinician and reassessing promptly after pregnancy begins.
Eligible patients may access testing through Ulta Lab Tests, but an order does not replace preconception care. Some tests may already be current, while other necessary assessments are not laboratory tests. Coordinate selection and interpretation with the team, especially when kidney disease, severe hypoglycemia, or medication changes may affect planning.
Bring existing records to a preconception appointment and discuss which A1C, serum creatinine, uACR, and thyroid measurements are needed. Explore the linked Ulta options with that plan in place, and continue with the broader pregnancy testing guide as prenatal care begins.
Preconception testing in type 1 diabetes assesses glucose exposure and relevant kidney, thyroid, and other health findings before pregnancy. Results support coordinated planning but do not provide stand-alone pregnancy clearance.
Relevant tests: A1C, serum creatinine, uACR, TSH, and selected free T4, CBC, or lipid panel.
Ulta Lab Tests provides relevant laboratory options for eligible patients to coordinate with their preconception care team.
Educational information only; laboratory results require clinical interpretation and do not replace individualized preconception or prenatal care.
| Category | Linked tests and role |
|---|---|
| Preconception glucose assessment | Hemoglobin A1C — reviewed alongside glucose-monitoring data and hypoglycemia history. |
| Kidney assessment | Creatinine and Urine Albumin-to-Creatinine Ratio. |
| Thyroid assessment | TSH, with selected Free T4 when indicated. |
| Blood-cell assessment | CBC with Differential and Platelets — when indicated by preconception care, symptoms, or medical history. |
| Cardiovascular and medication-review context | Lipid Panel — when due or relevant to treatment review; it is not a universal prenatal screening panel. |
Ulta Lab Tests, LLC.
9237 E Via de Ventura, Suite 220
Scottsdale, AZ 85258
480-681-4081
(Toll Free: 800-714-0424)
